Table of Contents 3
List of Tables 4
List of Figures 4
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
OptiNose US Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
OptiNose US Inc, Medical Devices Deals, 2011 to YTD 2017 10
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
OptiNose US Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
OptiNose Raises USD37 Million in Series D Financing 12
Optinose Raises USD30 Million in Venture Financing 13
Partnerships 14
OptiNose US Enters Into Collaboration with Oslo University Hospital, SINTEF and Smerud Medical Research International 14
Licensing Agreements 15
Avanir Pharma And OptiNose Enter Into Licensing Agreement For Treatment Of Acute Migraine 15
Equity Offering 17
OptiNose to Raise up to USD106.3 Million in IPO of Shares 17
Debt Offering 18
Optinose Raises USD15 Million in Private Placement of 17% Notes Due 2020 18
Optinose Raises USD15 Million in Private Placement of 17% Notes Due 2017 19
OptiNose US Inc - Key Competitors 20
OptiNose US Inc - Key Employees 21
OptiNose US Inc - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
Feb 09, 2017: OptiNose appoints chief legal officer 23
Product News 24
Sep 19, 2016: New Research Highlights the Burden of Illness Suffered by Chronic Rhinosinusitis Patients 24
02/01/2016: OptiNose Announces Pipeline Project to Evaluate Nose-to-Brain Application of Bi-Directional Breath Powered Technology Selected for Norwegian Government Funding 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
OptiNose US Inc, Pharmaceuticals & Healthcare, Key Facts 2
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
OptiNose US Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
OptiNose US Inc, Deals By Therapy Area, 2011 to YTD 2017 8
OptiNose US Inc, Medical Devices Deals, 2011 to YTD 2017 10
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
OptiNose Raises USD37 Million in Series D Financing 12
Optinose Raises USD30 Million in Venture Financing 13
OptiNose US Enters Into Collaboration with Oslo University Hospital, SINTEF and Smerud Medical Research International 14
Avanir Pharma And OptiNose Enter Into Licensing Agreement For Treatment Of Acute Migraine 15
OptiNose to Raise up to USD106.3 Million in IPO of Shares 17
Optinose Raises USD15 Million in Private Placement of 17% Notes Due 2020 18
Optinose Raises USD15 Million in Private Placement of 17% Notes Due 2017 19
OptiNose US Inc, Key Competitors 20
OptiNose US Inc, Key Employees 21
OptiNose US Inc, Subsidiaries 22

List of Figures
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
OptiNose US Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
OptiNose US Inc, Medical Devices Deals, 2011 to YTD 2017 10